NO20043633L - Oral doseringsform for kontrollert medikamentfrigivning - Google Patents

Oral doseringsform for kontrollert medikamentfrigivning

Info

Publication number: NO20043633L
Authority: NO; Norway
Prior art keywords: dosage form; oral dosage; drug release; controlled drug; controlled
Prior art date: 2002-02-12

Application number

NO20043633A

Other languages

English (en)

Other versions

NO334453B1 (no

Inventor

Vincenzo Re

Luigi Martini

Helen Anne Willy

Chi Leung Li

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-12

Filing date

2004-08-31

Publication date

2004-10-27

2002-02-12 Priority claimed from GB0203297A external-priority patent/GB0203297D0/en

2002-02-12 Priority claimed from GB0203298A external-priority patent/GB0203298D0/en

2002-02-12 Priority claimed from GBGB0203296.9A external-priority patent/GB0203296D0/en

2004-08-31 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2004-10-27 Publication of NO20043633L publication Critical patent/NO20043633L/no

2014-03-03 Publication of NO334453B1 publication Critical patent/NO334453B1/no

Links

238000013267 controlled drug release Methods 0.000 title 1
239000006186 oral dosage form Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Hematology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20043633A 2002-02-12 2004-08-31 Oral doseringsform for kontrollert medikamentfrigivning, fremgangsmåte for fremstilling samt anvendelse derav NO334453B1 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0203297A GB0203297D0 (en)	2002-02-12	2002-02-12	Novel composition
GB0203298A GB0203298D0 (en)	2002-02-12	2002-02-12	Novel composition
GBGB0203296.9A GB0203296D0 (en)	2002-02-12	2002-02-12	Novel composition
PCT/GB2003/000594 WO2003068195A1 (en)	2002-02-12	2003-02-12	Oral dosage form for controlled drug release

Publications (2)

Publication Number	Publication Date
NO20043633L true NO20043633L (no)	2004-10-27
NO334453B1 NO334453B1 (no)	2014-03-03

Family

ID=27738830

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043633A NO334453B1 (no)	2002-02-12	2004-08-31	Oral doseringsform for kontrollert medikamentfrigivning, fremgangsmåte for fremstilling samt anvendelse derav

Country Status (33)

Country	Link
EP (1)	EP1474114B1 (no)
JP (2)	JP2005526031A (no)
KR (2)	KR101048925B1 (no)
CN (1)	CN100444833C (no)
AP (1)	AP1736A (no)
AR (1)	AR038417A1 (no)
AT (1)	ATE455540T1 (no)
AU (1)	AU2003245763B2 (no)
BR (1)	BRPI0307319B8 (no)
CA (1)	CA2475544A1 (no)
CL (1)	CL2007003010A1 (no)
CO (1)	CO5601025A2 (no)
CY (1)	CY1109939T1 (no)
DE (1)	DE60331041D1 (no)
DK (1)	DK1474114T3 (no)
EA (1)	EA008286B1 (no)
EC (1)	ECSP045232A (no)
ES (1)	ES2336319T3 (no)
IL (1)	IL163098A (no)
IS (1)	IS2747B (no)
MA (1)	MA27689A1 (no)
MX (1)	MXPA04007794A (no)
MY (1)	MY139719A (no)
NO (1)	NO334453B1 (no)
NZ (1)	NZ534152A (no)
OA (1)	OA12770A (no)
PE (1)	PE20030800A1 (no)
PL (1)	PL206596B1 (no)
PT (1)	PT1474114E (no)
SI (1)	SI1474114T1 (no)
TW (1)	TWI286079B (no)
UY (1)	UY27660A1 (no)
WO (1)	WO2003068195A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0120835D0 (en)	2001-08-28	2001-10-17	Smithkline Beecham Plc	Process
GB0203296D0 (en)	2002-02-12	2002-03-27	Glaxo Group Ltd	Novel composition
US8637512B2 (en)	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
TW200517127A (en) *	2003-08-07	2005-06-01	Sb Pharmco Inc	Novel composition
GB0318824D0 (en) *	2003-08-11	2003-09-10	Glaxo Group Ltd	Novel composition
US7879354B2 (en)	2004-01-13	2011-02-01	Mcneil-Ppc, Inc.	Rapidly disintegrating gelatinous coated tablets
US20070190145A1 (en) *	2006-01-27	2007-08-16	Eurand, Inc.	Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids
EP2387994A1 (en) *	2006-01-27	2011-11-23	Eurand, Inc.	Drug delivery systems comprising weakly basic drugs and organic acids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2150830B (en) *	1983-12-05	1987-08-19	Alza Corp	Drug dispenser
GB8820353D0 (en) *	1988-08-26	1988-09-28	Staniforth J N	Controlled release tablet
US6099859A (en) *	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
EA007610B1 (ru) *	1998-11-12	2006-12-29	Смитклайн Бичам Плс	Таблетка с энтеропокрытием, обеспечивающая отсроченное высвобождение
AR023700A1 (es) *	1998-11-12	2002-09-04	Smithkline Beecham Plc	Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
GB0027471D0 (en) *	2000-11-08	2000-12-27	Smithkline Beecham Plc	Processes

2003
- 2003-02-10 MY MYPI20030447A patent/MY139719A/en unknown
- 2003-02-10 PE PE2003000145A patent/PE20030800A1/es active IP Right Grant
- 2003-02-11 UY UY27660A patent/UY27660A1/es not_active IP Right Cessation
- 2003-02-11 AR ARP030100422A patent/AR038417A1/es not_active Application Discontinuation
- 2003-02-11 TW TW092102772A patent/TWI286079B/zh not_active IP Right Cessation
- 2003-02-12 JP JP2003567378A patent/JP2005526031A/ja not_active Withdrawn
- 2003-02-12 SI SI200331764T patent/SI1474114T1/sl unknown
- 2003-02-12 CA CA002475544A patent/CA2475544A1/en not_active Abandoned
- 2003-02-12 CN CNB038037378A patent/CN100444833C/zh not_active Expired - Lifetime
- 2003-02-12 AT AT03739557T patent/ATE455540T1/de active
- 2003-02-12 KR KR1020047012361A patent/KR101048925B1/ko not_active Expired - Lifetime
- 2003-02-12 KR KR1020107015064A patent/KR20100086084A/ko not_active Ceased
- 2003-02-12 PL PL371368A patent/PL206596B1/pl unknown
- 2003-02-12 AP APAP/P/2004/003087A patent/AP1736A/en active
- 2003-02-12 AU AU2003245763A patent/AU2003245763B2/en not_active Expired
- 2003-02-12 ES ES03739557T patent/ES2336319T3/es not_active Expired - Lifetime
- 2003-02-12 DE DE60331041T patent/DE60331041D1/de not_active Expired - Lifetime
- 2003-02-12 NZ NZ534152A patent/NZ534152A/en not_active IP Right Cessation
- 2003-02-12 PT PT03739557T patent/PT1474114E/pt unknown
- 2003-02-12 OA OA1200400209A patent/OA12770A/en unknown
- 2003-02-12 WO PCT/GB2003/000594 patent/WO2003068195A1/en not_active Ceased
- 2003-02-12 MX MXPA04007794A patent/MXPA04007794A/es active IP Right Grant
- 2003-02-12 DK DK03739557.1T patent/DK1474114T3/da active
- 2003-02-12 EA EA200401071A patent/EA008286B1/ru not_active IP Right Cessation
- 2003-02-12 EP EP03739557A patent/EP1474114B1/en not_active Expired - Lifetime
- 2003-02-12 BR BRPI0307319A patent/BRPI0307319B8/pt not_active IP Right Cessation
2004
- 2004-07-19 IL IL163098A patent/IL163098A/en active IP Right Grant
- 2004-08-05 IS IS7383A patent/IS2747B/is unknown
- 2004-08-09 CO CO04077244A patent/CO5601025A2/es not_active Application Discontinuation
- 2004-08-12 EC EC2004005232A patent/ECSP045232A/es unknown
- 2004-08-12 MA MA27822A patent/MA27689A1/fr unknown
- 2004-08-31 NO NO20043633A patent/NO334453B1/no not_active IP Right Cessation
2007
- 2007-10-19 CL CL2007003010A patent/CL2007003010A1/es unknown
2010
- 2010-03-31 CY CY20101100304T patent/CY1109939T1/el unknown
- 2010-04-22 JP JP2010098906A patent/JP5279757B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2475544A1 (en)	2003-08-21
ES2336319T3 (es)	2010-04-12
KR20040084900A (ko)	2004-10-06
IS2747B (is)	2011-08-15
UY27660A1 (es)	2003-09-30
DK1474114T3 (da)	2010-04-12
ATE455540T1 (de)	2010-02-15
PE20030800A1 (es)	2003-10-31
HK1072194A1 (en)	2005-08-19
PL371368A1 (en)	2005-06-13
EP1474114A1 (en)	2004-11-10
TW200307567A (en)	2003-12-16
KR20100086084A (ko)	2010-07-29
DE60331041D1 (de)	2010-03-11
AP2004003087A0 (en)	2004-09-30
BRPI0307319B1 (pt)	2018-05-02
PT1474114E (pt)	2010-03-04
EA008286B1 (ru)	2007-04-27
ECSP045232A (es)	2004-09-28
NZ534152A (en)	2006-11-30
JP2010159301A (ja)	2010-07-22
WO2003068195A1 (en)	2003-08-21
CY1109939T1 (el)	2014-09-10
AR038417A1 (es)	2005-01-12
PL206596B1 (pl)	2010-08-31
TWI286079B (en)	2007-09-01
MY139719A (en)	2009-10-30
OA12770A (en)	2006-07-04
NO334453B1 (no)	2014-03-03
AU2003245763A1 (en)	2003-09-04
BR0307319A (pt)	2005-01-04
CN100444833C (zh)	2008-12-24
BRPI0307319B8 (pt)	2021-05-25
JP2005526031A (ja)	2005-09-02
IS7383A (is)	2004-08-05
MXPA04007794A (es)	2004-10-15
IL163098A (en)	2009-05-04
CL2007003010A1 (es)	2008-01-25
JP5279757B2 (ja)	2013-09-04
CO5601025A2 (es)	2006-01-31
CN1655768A (zh)	2005-08-17
EP1474114B1 (en)	2010-01-20
AU2003245763B2 (en)	2008-12-11
SI1474114T1 (sl)	2010-04-30
EA200401071A1 (ru)	2004-12-30
KR101048925B1 (ko)	2011-07-12
AP1736A (en)	2007-05-02
MA27689A1 (fr)	2006-01-02

Legal Events

Date	Code	Title	Description
2013-05-21	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: GLAXO GROUP LTD, GB
2023-03-06	MK1K	Patent expired

Publication	Publication Date	Title
EP1477403A4 (en)	2009-11-11	MEDICINES SUPPLY
EP1553925A4 (en)	2012-09-05	ORAL DOSAGE FORM WITH MODIFIED RELEASE
PT1501534E (pt)	2006-09-29	Formulacoes farmaceuticas
EP1469812A4 (en)	2010-09-29	ORAL INSULIN THERAPY
DE60308372D1 (de)	2006-10-26	Dosierungsverabreichungsvorrichtung
CY2007031I2 (el)	2009-11-04	Συνθεση στοματικης δοσολογιας παρατεταμενης απελευθερωσης
ATE372765T1 (de)	2007-09-15	Feste pharmazeutische formulierungen mit telmisartan
NO20030627L (no)	2003-04-08	Hydrogel-drevet medikament doseringsform
CY2018005I2 (el)	2018-06-27	Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
PL377495A1 (pl)	2006-02-06	Stały lek do stosowania doustnego
IS7481A (is)	2004-09-30	Epóthílon til gjafar um munn
IL176519A0 (en)	2006-10-05	Directly compressible pharmaceutical composition for the oral administration of cci-779
FI20000780L (fi)	2001-10-04	Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO20041383L (no)	2004-06-01	Flashsmelte oral doseringsformulering
ATE551051T1 (de)	2012-04-15	Orales arzneimittelabgabesystem
ATE327759T1 (de)	2006-06-15	Pharmazeutische zusammensetzung mit verlungerter freisetzung
NO20044188L (no)	2004-12-03	Kontrollerte frigjoringsdoseformer
DE60336999D1 (de)	2011-06-16	Melatonin enthaltende pharmazeutische formulierung
NO20043633L (no)	2004-10-27	Oral doseringsform for kontrollert medikamentfrigivning
AU2003261067A8 (en)	2004-04-30	Modified release ketoprofen dosage form
NO20043007L (no)	2004-07-15	Farmasoytisk suspensjon for oral administrering
DE502004003170D1 (de)	2007-04-19	Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
ITTO20020672A1 (it)	2004-01-26	Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
GB0322848D0 (en)	2003-10-29	Tetracycline controlled release pharmaceutical dosage form
ITMI20020921A0 (it)	2002-04-30	Dispositivo per la sommistrazione di farmaci